5 completed, 1 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Unknown 1 |
Follow Developmental Disabilities: new trials by email Literature Review of Developmental Disabilities trials Research Report on Developmental Disabilities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical and Cost Effectiveness of Positive Behaviour Support: a Trial PBS based staff training, Treatment as Usual - Challenging Behaviour | Phase 3 | Unknown | University College, London | 246 | 2012-11-01 | 2016-05-23 |
| Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities Fast Release Melatonin (FR MLT), Fast Release Placebo, Timed Release Melatonin (TR MLT) - Epilepsy, Insomnia | Phase 3 | Completed | The Hospital for Sick Children | 13 | 2010-07-01 | 2014-12-02 |
| Supporting the Well Being of Families of Young Children With Autism Spectrum Disorders Problem Solving Education - Maternal Depression | Phase 3 | Completed | Boston Medical Center | 122 | 2009-09-01 | 2013-04-29 |
| Caffeine for Apnea of Prematurity (CAP) Caffeine citrate injection - Apnea of Prematurity | Phase 3 | Completed | McMaster University | 2000 | 1999-10-01 | 2018-03-22 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD) risperidone - DCild Development Disorders, Pervasive, Autistic Disorder | Phase 3 | Completed | Janssen-Ortho Inc., Canada | 80 | 1999-08-01 | 2011-01-24 |
| Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay risperidone, clozapine, olanzapine - Mental Retardation, Developmental Delay Disorder | Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 50 | 1998-07-01 | 2005-06-24 |
Intellectual Disability (2) · Apnea (1) · Asperger Syndrome (1) · Autistic Disorder (1) · Child Development Disorders, Pervasive (1) · Depression (1) · Epilepsy (1) · Mental Disorders (1) · Rett Syndrome (1) · Sleep Initiation and Maintenance Disorders (1)
Neurodevelopmental Disorders (6) · Mental Disorders (5) · Nervous System Diseases (4) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Autism Spectrum Disorder (1) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dyssomnias (1) · Genetic Diseases, Inborn (1)
Risperidone (2) · Clozapine (1) · Olanzapine (1) · Therapeutics (1) · caffeine citrate (1)
Boston Medical Center (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Janssen-Ortho Inc., Canada (1) · McMaster University (1) · The Hospital for Sick Children (1) · University College, London (1)
United States (3) · Canada (2) · United Kingdom (2) · Australia (1) · Germany (1) · Israel (1) · Netherlands (1) · Sweden (1) · Switzerland (1)
Alfonso Solimano, MD (1) · Andre Strydom, MD PhD (1) · Arne Ohlsson, MD (1) · Barbara K Schmidt, MD (1) · Deborah Dewey, MD (1) · Diane Moddemann, MD (1) · Elizabeth Asztalos, MD (1) · Ian Hall, MBBS MPhil (1) · Keith J Barrington, MD (1) · Lex Doyle, MD (1) · Michael King, FRCGP PhD (1) · Peter Anderson, PhD (1) · Peter Davis, MD (1) · Rachael Hunter (1)
PMID 15492353, PMID 16707748, PMID 17989382, PMID 19926098, PMID 21173002, PMID 22253394, PMID 24217336, PMID 24496539, PMID 24840756, PMID 25641237, PMID 25784749, PMID 28437520, PMID 28707987, PMID 29436314, PMID 29596045, PMID 32019635, PMID 32293383
P01HD026927 (1)